ArticlePharmacoEconomics - open2026

Cost-Effectiveness of RefluxStop Versus Nissen Fundoplication and Proton Pump Inhibitors for Refractory Gastroesophageal Reflux Disease: A Spanish Healthcare Perspective.

Sam Harper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.